How much does Pajunk U.K. Medical Products Limited make?

Pajunk U.K. Medical Products Limited reported revenue of £15.8m and £2.5m profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Pajunk U.K. Medical Products Limited have?

Pajunk U.K. Medical Products Limited reported an average of 22 employees in the year to 31 Dec 2025.

Is Pajunk U.K. Medical Products Limited profitable?

Yes — Pajunk U.K. Medical Products Limited reported a profit of £2.5m in the year to 31 Dec 2025.

Company No. 04112014 · Incorporated 22 Nov 2000

Pajunk U.K. Medical Products Limited

Registered name: PAJUNK U.K. MEDICAL PRODUCTS LIMITED

Part of Pajunk Holding Ag group

Pajunk U.K. Medical Products Limited made £15.8m revenue and £2.5m profit in the year to 31 Dec 2025. read from filing text

Pajunk U.K. Medical Products Limited’s revenue grew 5% to £15.8m in the year to 31 Dec 2025, with £2.5m profit and 22 employees. The company is classified under “hospital activities” and is based in Stanley; we hold 4 years of its filed accounts.

Full P&L filedSection Q · Human health and social workSIC 86101Hospital activities

Status: Active
Location: Stanley, North East
Age: 25 yrs · since 2000
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Pajunk UK Medical Products Limited is a subsidiary of Pajunk Holding AG, a company registered in Germany.”

Latest accounts · year to 31 Dec 2025

Key figures

Capital-lightOperating leverageCash flow filed

Revenue

£15.8m

Growth ▲5.1%

Profit

£2.5m

Growth ▲13.7%

Profit margin

15.8%

Gross 39%

Employees

Change ▲4.8%

Profit / employee

£114k

Revenue/employee £719k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	£10.3m	£12.7m	£15m	£15.8m
Cost of sales	£6.1m	£7.4m	£8.9m	£9.7m
Gross profit	£4.2m	£5.3m	£6.1m	£6.2m
Operating profit	£1.2m	£2.2m	£2.9m	£2.9m
Profit before tax	£1.2m	£2.2m	£2.9m	£2.9m
Profit after tax	£1m	£1.8m	£2.2m	£2.5m
Profit (best available)	£1m	£1.8m	£2.2m	£2.5m
Staff costs	£1.7m	£1.8m	£2.2m	£2.1m
Employees (average)	18	18	21	22
Ratios
Profit margin	10.2%	14.1%	14.6%	15.8%
Gross margin	40.6%	41.8%	40.8%	39%
Revenue per employee	£571k	£707k	£717k	£719k
Profit per employee	£58k	£99.3k	£105k	£114k
Cash conversion	−167.5%	−51.1%	−86.6%	−75.7%
Growth (year on year)
Revenue growth	—	▲23.8%	▲18.3%	▲5.1%
Profit growth	—	▲71.1%	▲23.1%	▲13.7%
Headcount growth	—	0%	▲16.7%	▲4.8%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.4m	£880k	£1.2m	£1.1m
Net assets	£928k	£1.5m	£2.1m	£2.6m
Fixed assets	£42.7k	£32.7k	£29.6k	£27.2k
Current assets	£5.3m	£5.3m	£6.8m	£6.8m
Debtors	£1.3m	£1.2m	£1.5m	£1.4m
Deferred income	£138k	£231k	£656k	£177k
Cash from operations	−£2m	−£1.1m	−£2.5m	−£2.2m
Source	FullAccounts · bulk data Aug 2024	FullAccounts · bulk data Aug 2024	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Aug 2026

Derived from the latest filing

How the business works

Profit margin: 15.8%; Profit ÷ revenue.
Gross margin: 39%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £719k; Revenue ÷ average employees.
Profit per employee: £114k; Profit ÷ average employees.
Cash conversion: −75.7%; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 0.2%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 1.1%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 8.9%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲23%; Now £2.6m
Cash at bank: ▼10%; Now £1.1m
Headcount: ▲5%; Now 22
Deferred income: ▼73%; Now £177k
Fixed assets: ▼8%; Now £27.2k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Pajunk Holding Ag (registered outside the UK register)ultimate parent75–100%
Pajunk U.K. Medical Products Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £2.5m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.